(Q30395810)

21 June 2017

title

Nasal vaccine innovation (English)

1 reference

21 June 2017

Inderjit Jabbal-Gill

1

1 reference

21 June 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21047271

19 August 2024

publication date

1 December 2010

1 reference

full work available at URL

21 June 2017

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Journal of Drug Targeting

19 August 2024

published in

1 reference

21 June 2017

volume

18

1 reference

21 June 2017

issue

10

1 reference

21 June 2017

page(s)

771-786

1 reference

Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Chitosan-based delivery systems for protein therapeutics and antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Chitosan-based systems for the delivery of vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Role of influenza vaccine for healthy children in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Lipid based particulate formulations for the delivery of antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Applications of influenza virosomes as a delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Virosomes for antigen and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

An open-label comparison of the immunogenicity and tolerability of intranasal and intramuscular formulations of virosomal influenza vaccine in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Effect of chitosan on epithelial permeability and structure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

The role of M cells of human nasopharyngeal lymphoid tissue in influenza virus sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Comparison of the mucoadhesive properties of various polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Adjuvants--a balance between toxicity and adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Effect of Viscosity on Particle Size, Deposition, and Clearance of Nasal Delivery Systems Containing Desmopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Immunostimulating complexes (ISCOMs) for nasal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

The virosome concept for influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Chitosan as a novel nasal delivery system for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Polymeric lamellar substrate particles for intranasal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Nanoparticles as carriers for nasal vaccine delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

The role of nasopharyngeal lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

ISCOM based vaccines for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Induction, function and regulation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Adjuvant synergy: the effects of nasal coadministration of adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Epithelial M cells: gateways for mucosal infection and immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Recent advances in the discovery and delivery of vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Modeling chromatographic columns non-equilibrium packed-bed adsorption with non-linear adsorption isotherms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Race for pandemic flu vaccine rife with hurdles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Single dose intranasal immunization with ISCOMATRIX vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

The basics and underlying mechanisms of mucoadhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Potential applications of chitosan in veterinary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Advances in saponin-based adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Adjuvant activity of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Adverse events associated with intranasal influenza vaccine in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Synthetic biomimetic supra molecular Biovector (SMBV) particles for nasal vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Predictions for Future Human Influenza Pandemics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

New loading process and release properties of insulin from polysaccharide microcapsules fabricated through layer-by-layer assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Efficient delivery of DNA to dendritic cells mediated by influenza virosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.523790

Zymosan enhances the mucosal adjuvant activity of poly(I:C) in a nasal influenza vaccine

21 January 2018

3

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model

19 August 2024

5

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Stimulation of secretory antibodies against Bordetella pertussis antigens in the lungs of mice after oral or intranasal administration of liposome-incorporated cell-surface antigens

19 August 2024

11

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Comparison of the clearance of radiolabelled nose drops and nasal spray as mucosally delivered vaccine

19 August 2024

12

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Intranasal immunization with proteoliposomes protects against influenza

19 August 2024

21

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

19 August 2024

32

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Intranasal drug delivery by spray and drops

19 August 2024

33

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Erratum: A Toll-like receptor recognizes bacterial DNA

19 August 2024

36

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin

19 August 2024

37

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Nasal vaccination: a non-invasive vaccine delivery method that holds great promise for the future

19 August 2024

42

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Adverse events reported following live, cold-adapted, intranasal influenza vaccine

19 August 2024

44

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

CpG motifs as immune adjuvants

19 August 2024

53

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist

19 August 2024

55

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

CpG-A Oligonucleotides Induce a Monocyte-Derived Dendritic Cell-Like Phenotype That Preferentially Activates CD8 T Cells

19 August 2024

57

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes

19 August 2024

61

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Particulate systems as adjuvants and carriers for peptide and protein antigens

19 August 2024

62

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Targeting immune response induction with cochleate and liposome-based vaccines

19 August 2024

65

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

19 August 2024

70

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Safety evaluation of calcium administered intranasally to mice

19 August 2024

74

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Protein release from polyphosphazene matrices

19 August 2024

75

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Yersinia pestis--etiologic agent of plague

19 August 2024

76

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Effective nasal influenza vaccine delivery using chitosan

19 August 2024

79

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

A novel bioadhesive intranasal delivery system for inactivated influenza vaccines

19 August 2024

87

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Evaluation of the clearance characteristics of bioadhesive systems in humans

19 August 2024

92

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Mutant Escherichia coli enterotoxin as a mucosal adjuvant induces specific Th1 responses of CD4+ and CD8+ T cells to nasal killed-bacillus calmette-guerin in mice

19 August 2024

97

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects

19 August 2024

99

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

Enterotoxin adjuvants have direct effects on T cells and antigen-presenting cells that result in either interleukin-4-dependent or -independent immune responses

19 August 2024

111

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.523790

19 August 2024

Identifiers

1 reference

21 June 2017

1 reference